Eileen Schwartz
Psychiatry · Akron, OHNPI 1043308299
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 661 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,389, 5.4 times the $445 reported in 2019. Among psychiatry clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 661 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$1K
- Lundbeck LLC$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$948
- plus $2K from 9 others
What the payments were for
- Food & beverage$9,93899%
- Education$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 97 | $1,600 |
| Alkermes, Inc. | 87 | $1,491 |
| Otsuka America Pharmaceutical, Inc. | 69 | $1,223 |
| AbbVie(2 entities) | 79 | $1,170 |
| Lundbeck LLC | 68 | $1,112 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 91 | $948 |
| Teva Pharmaceuticals USA, Inc. | 76 | $844 |
| Neurocrine Biosciences, Inc. | 42 | $669 |
| Indivior Inc. | 19 | $361 |
| E.r. Squibb & Sons, L.L.C. | 15 | $250 |
| Vanda Pharmaceuticals Inc. | 7 | $167 |
| Sunovion Pharmaceuticals Inc. | 5 | $59 |
| Braeburn Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Noven Therapeutics, LLC | 1 | $11 |
How this compares
$9,997 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 319 | $963,823 |
| Austedo XrDeutetrabenazine | 60 | $400,161 |
| IngrezzaValbenazine Tosylate | 38 | $291,476 |
| AustedoDeutetrabenazine | 41 | $201,083 |
| Invega TrinzaPaliperidone Palmitate | 17 | $82,983 |
| Abilify MaintenaAripiprazole | 32 | $76,693 |
| AristadaAripiprazole Lauroxil | 21 | $61,590 |
| LybalviOlanzapine/Samidorphan Malate | 37 | $61,584 |
| UzedyRisperidone | 14 | $39,601 |
| Clozapine | 529 | $30,884 |
| VraylarCariprazine Hcl | 23 | $30,468 |
| Risperdal ConstaRisperidone Microspheres | 13 | $11,261 |
| Paliperidone ErPaliperidone | 97 | $10,597 |
| Clozapine OdtClozapine | 29 | $10,587 |
| TrintellixVortioxetine Hydrobromide | 15 | $9,867 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta | $1,600 | $1,058,067349 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo, Uzedy | $844 | $640,845115 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $669 | $291,47638 claims |
| Alkermes, Inc.Aristada, Lybalvi | $1,491 | $123,17358 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $1,223 | $76,69332 claims |
| AbbVieVraylar | $1,170 | $30,46823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Akron
- Henry NasrallahCincinnati$3.8M
- Fred RomeoColumbus$2.3M
- Amita PatelDayton$2.1M
- Pradeep ManudhaneCanton$1.5M
- Michael SaribalasColumbus$1.2M
- Kevin WareColumbus$1.1M
- Binit ShahCleveland$913K
- Paul KeckCincinnati$739K
- Ali MelhemSteubenville$681K
- Tracey SkaleCincinnati$674K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.